Viatris Inc. Common Stock VTRS
$16.23
+1.18%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (3 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $17.40
- Implied Upside
- +7.2%
- Price Target Range
- $12.00 – $22.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-19 | BarclaysGlen Santangelo |
Maintains | Overweight | $17 → $22 |
| 2026-05-08 | JP MorganChris Schott |
Maintains | Neutral | $17 → $18 |
| 2026-05-08 | Truist SecuritiesSrikripa Devarakonda |
Maintains | Buy | $18 → $20 |
| 2026-03-24 | BarclaysGlen Santangelo |
Maintains | Overweight | $15 → $17 |
| 2026-01-28 | Piper SandlerDavid Amsellem |
Maintains | Neutral | $9 → $12 |
| 2026-01-16 | Argus Research |
Upgrades | Hold → Buy | $15 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Overweight | $15 |
| 2025-10-15 | Truist SecuritiesSrikripa Devarakonda |
Initiates coverage on | Buy | $15 |
| 2025-06-06 | Goldman SachsMatt Dellatorre |
Initiates coverage on | Neutral | $10 |
| 2025-03-07 | JefferiesGlen Santangelo |
Maintains | Buy | $15 → $13 |
| 2025-03-05 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $14 → $10 |
| 2025-02-28 | BarclaysBalaji Prasad |
Maintains | Underweight | $12 → $9 |
| 2025-02-28 | B of A SecuritiesJason Gerberry |
Maintains | Underperform | $11 → $10 |
| 2024-12-06 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $13 → $14 |
| 2024-11-08 | BarclaysBalaji Prasad |
Maintains | Underweight | $11 → $12 |
| 2024-07-19 | JefferiesGlen Santangelo |
Reinstates | Buy | $15 |
| 2024-03-28 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $11 → $13 |
| 2023-11-22 | Piper SandlerDavid Amsellem |
Maintains | Neutral | $10 → $11 |
| 2023-10-23 | B of A SecuritiesJason Gerberry |
Downgrades | Neutral → Underperform | $9 |
| 2023-06-23 | BarclaysBalaji Prasad |
Downgrades | Equal-weight → Underweight | $11 |
| 2023-04-25 | BarclaysBalaji Prasad |
Downgrades | Overweight → Equal-weight | $16 → $11 |
| 2023-04-24 | BarclaysBalaji Prasad |
Downgrades | Overweight → Equal-weight | $11 |
| 2023-02-28 | BarclaysBalaji Prasad |
Maintains | Overweight | $15 → $16 |
| 2023-02-17 | BMO CapitalGary Nachman |
Downgrades | Outperform → Market perform | $16 → $14 |
| 2023-02-01 | BarclaysBalaji Prasad |
Maintains | Overweight | $16 → $15 |
| 2023-01-27 | JefferiesGlen Santangelo |
Upgrades | Hold → Buy | $13 → $15 |
| 2022-11-15 | JP MorganChris Schott |
Maintains | Neutral | $13 → $14 |
| 2022-11-10 | UBSAshwani Verma |
Upgrades | Sell → Neutral | $9 → $12 |
| 2022-11-08 | Piper SandlerDavid Amsellem |
Upgrades | Underweight → Neutral | $10 |
| 2022-10-25 | BarclaysBalaji Prasad |
Maintains | Overweight | $21 → $16 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.23
- Market Cap
- $18.49 billion
- 52-Week Range
- $8.63 – $18.39
- Average Volume
- 10.44 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.